Delivery Order 36F79720D0227-36E79721N0044

Award Date 7/7/21
Potential Completion Date 9/14/25
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Boca Raton, FL 33432, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This estimated delivery order for $46,792.80 was awarded to Exelan Pharmaceuticals Inc. by the Department of Veterans Affairs National Acquisition Center on March 5, 2021. The order is for citalopram to support the Pharmaceutical Repackaging Program through September 14, 2021. It was issued against the company's GSA Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB), with a firm fixed price and place of performance in Boca Raton, Florida. No set-aside designation was used for this order...
This estimated $29,908.80 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) was awarded by the Department of Veterans Affairs National Acquisition Center to Exelan Pharmaceuticals Inc. for the delivery of citalopram to support the agency's Pharm Repackaging Program through September 2021. To be performed in Boca Raton, Florida, the firm fixed price order calls for Exelan Pharmaceuticals, the prime contractor, to provide the generic antidepressant medication...
The Department of Veterans Affairs National Acquisition Center awarded Exelan Pharmaceuticals Inc. an estimated delivery order valued at forty thousand five hundred twenty-one dollars and sixty cents ($40,521.60) for the delivery of citalopram to support the Pharmaceutical Repackaging Program from August 2021 through September 2025. The order was issued against Exelan's Pharmaceuticals and Drugs contract (FSS-61-IB) under the General Services Administration Schedule with firm fixed pricing. To...
This delivery order for an estimated $29,908.80 was awarded by the Department of Veterans Affairs National Acquisition Center to Exelan Pharmaceuticals Inc. on February 3, 2021. The order is associated with the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and is for the delivery of citalopram to support the agency's Pharm Repackaging Program through September 14, 2021. The order has a firm fixed price and will be performed by Exelan Pharmaceuticals in Boca Raton, Florida. No...
This delivery order, awarded by the Department of Veterans Affairs National Acquisition Center to Exelan Pharmaceuticals Inc., is for an estimated $39,074.40 to supply citalopram through September 2021 for the agency's Pharmaceutical Repackaging Program. Issued against Exelan's GSA Schedule contract for pharmaceuticals and drugs, the firm fixed price order has no set-aside designation. It will support the VA's efforts to provide prescription medications to veterans through its pharmacies by...
This is a Firm Fixed Price delivery/task order contract awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract, valued at $92,160.00, is for the delivery of the drug citalopram to support the VA's Pharmaceutical Repackaging Program. This order is placed under Exelan's existing Federal Supply Schedule (FSS-61-IB) contract for Pharmaceuticals and...
This is a firm fixed-price contract awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract is for the delivery of Citalopram 40mg, a generic antidepressant medication, with a ceiling value of $90,000.00. This contract was awarded as an unrestricted procurement with no set-aside designation, allowing Exelan to compete based on its capabilities and...
This is a firm fixed-price contract awarded by the Department of Veterans Affairs (VA) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract is for the delivery of Citalopram 40mg, a generic antidepressant medication, with a ceiling value of $77,400.00. The contract was awarded on January 14, 2016 and has an ultimate completion date of the same day, indicating it was likely a one-time or short-term delivery order. The...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call issued by the Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract is for the bulk purchase of the drug citalopram to support the VA's Pharmaceutical Repackaging Program, which consolidates and repackages bulk drug products into individual prescriptions. The contract has a ceiling value of...
This is a firm fixed-price contract awarded by the Department of Veterans Affairs (VA) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract is for the delivery of the medication citalopram 40mg, which is a common antidepressant drug. The contract was awarded under the VA's Pharmaceutical and Drugs Federal Supply Schedule (FSS-61-IB) and has a ceiling value of $77,400.00. Exelan Pharmaceuticals is an experienced federal...

This estimated delivery order for $19,296 is for citalopram to be delivered by September 2025 for the Department of Veterans Affairs National Acquisition Center's Pharmaceutical Repackaging Program. Exelan Pharmaceuticals Inc. of Boca Raton, Florida was awarded this firm fixed price delivery order under the company's GSA Schedule Pharmaceuticals and Drugs contract, which has no set aside designation. The delivery order is for citalopram to support the VA's mission to provide quality healthcare to veterans through its pharmaceutical repackaging initiative, which consolidates and repackages drugs to improve formulary management and reduce costs.

Generated 1/3/24, 5:39 AM